Pharvaris N.V. ( PHVS) - Key Metrics
PHVS Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0 | -$0.70 | -$0.56 | -$0.56 |
| 2026Q1 | $0 | -$0.61 | -$0.76 | -$0.76 |
| 2025Q4 | $0 | -$0.79 | -$0.64 | -$0.64 |
| 2025Q3 | $0 | -$0.60 | -$0.49 | -$0.49 |
| 2025Q2 | $0 | -$0.83 | -$0.55 | -$0.55 |
PHVS Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -10.81 |
| 2026Q1 | 0% | -10.02 |
| 2025Q4 | 0% | -7.47 |
| 2025Q3 | 0% | -8.86 |
| 2025Q2 | 0% | -4.50 |
PHVS
Price: $35.25
52 week price:
Earnings Per Share: -3.00 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: Netherlands
Volume: 38200
Market Capitalization: 2.5 billion